Eli Lilly & Co. (LLY) Tops Q2 EPS by 13c; raises guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,417.99 +0.61%
Financial Fact:
Marketing, selling, and administrative: 1.57B
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Marketing, selling, and administrative: 1.57B
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q2 EPS of $2.11, $0.13 better than the analyst estimate of $1.98. Revenue for the quarter came in at $8.31 billion versus the consensus estimate of $7.58 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2023 EPS of $9.70-$9.90, versus the consensus of $8.71. Eli Lilly & Co. sees FY2023 revenue of $33.4-33.9 billion, versus the consensus of $31.44 billion.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vertex (VERX) Tops Q3 EPS by 4c; Offers Guidance
- ACRES Commercial Realty (ACR) Misses Q3 EPS by 526c
- Relay Therapeutics, Inc. (RLAY) Tops Q3 EPS by 3c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
